Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Current Leases (2020 - 2024)

Mirum Pharmaceuticals (MIRM) has 5 years of Current Leases data on record, last reported at $1.7 million in Q4 2024.

  • For Q4 2024, Current Leases rose 54.8% year-over-year to $1.7 million; the TTM value through Dec 2024 reached $1.7 million, up 54.8%, while the annual FY2024 figure was $1.7 million, 54.8% up from the prior year.
  • Current Leases reached $1.7 million in Q4 2024 per MIRM's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.7 million in Q4 2024 and bottomed at $358000.0 in Q1 2024.
  • Average Current Leases over 5 years is $850800.0, with a median of $741500.0 recorded in 2022.
  • The widest YoY moves for Current Leases: up 54.8% in 2024, down 60.83% in 2024.
  • A 5-year view of Current Leases shows it stood at $636000.0 in 2020, then increased by 11.79% to $711000.0 in 2021, then surged by 30.94% to $931000.0 in 2022, then rose by 18.58% to $1.1 million in 2023, then soared by 54.8% to $1.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Current Leases were $1.7 million in Q4 2024, $1.5 million in Q3 2024, and $1.1 million in Q2 2024.